SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-014930
Filing Date
2017-02-27
Accepted
2017-02-27 18:15:25
Documents
1
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 5 SUBMISSION doc5.html 5  
1 FORM 5 SUBMISSION doc5.xml 5 7147
  Complete submission text file 0001209191-17-014930.txt   8571
Mailing Address 7020 KIT CREEK ROAD SUITE 270 RESEARCH TRIANGLE PARK NC 27709
Business Address 7020 KIT CREEK ROAD SUITE 270 RESEARCH TRIANGLE PARK NC 27709 919-313-9650
AERIE PHARMACEUTICALS INC (Issuer) CIK: 0001337553 (see all company filings)

IRS No.: 203109565 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 135 U.S. HIGHWAY 206 SUITE 15 BEDMINSTER NJ 07921
Business Address
Kopczynski Casey C. (Reporting) CIK: 0001590001 (see all company filings)

Type: 5 | Act: 34 | File No.: 001-36152 | Film No.: 17643711